PharVision Advisers, LLC: FLWS position timeline

PharVision Advisers, LLC held 10,680 FLWS shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

1. period ended2026-06-30

   13F 10,680 shares

   Change vs previous 13F +10,680 shares

   0.7% of the 13F portfolio, value $37,166.

   13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
   Filed 2026-08-11 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2025-12-31

   13F 0 shares

   Change vs previous 13F -34,044 shares

   13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
   Filed 2026-02-17 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

3. period ended2025-09-30

   13F 34,044 shares

   Change vs previous 13F +34,044 shares

   0.09% of the 13F portfolio, value $156,602.

   13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
   Filed 2025-11-17 (acceptance time not in the bulk data set), ingested 2026-10-07 03:02:25 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-06-30

   13F 0 shares

   Change vs previous 13F -18,590 shares

   13F-HR 0001420506-25-001926 filed by PharVision Advisers, LLC
   Filed 2025-08-13 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

5. period ended2025-03-31

   13F 18,590 shares

   Change vs previous 13F not available

   0.15% of the 13F portfolio, value $109,681.

   13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
   Filed 2025-05-15 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:06 UTC

   Acceptance time not in the bulk data set (spec §4.2).